Korelasi Ekspresi Protein HIF-2 Alfa dengan Rasio BCR-ABL/ABL pada Pasien LGK Fase Kronik yang Mendapat Hidroksia Urea sebelum Imatinib Mesilate = HIF-2 Alpha Protein Expression Correlation with BCR-ABL/ABL ratio in CML Chronic Phase Patients who Received Hydroxy Urea before Imatinib Mesilate

Peran Mutasi Gen BCR-Abl pada Perjalanan Klinis Pasien Leukemia Granulositik Kronik (LGK): Kaitannya dengan Aspek Terapi Imatinib Mesylate (IM) = The Role of BCR-Abl Gene Mutation in Clinical Course of Chronic Myeloid Leukemia Patients (CML): Relation to Aspects of Imatinib Mesylate Therapy (IM)

Kualitas hidup dan tingkat kepatuhan penggunaan imatinib mesilat pada pasien Leukemia Granulositik Kronik di RS Kanker Dharmais Jakarta = Quality of life and adherence to imatinib mesylate therapy inchronic myeloid Leukemia Patients at Dharmais Cancer Hospital Jakarta

Hubungan Mutasi T315I Gen ABL1 dengan Pencapaian Major Molecular Response (MMR) pada Pasien Leukemia Granulositik Kronik Fase Kronik yang Mendapat Imatinib = Association between T315I Mutation in ABL1 Gene to the Achievement of Major Molecular Response (MMR) in Chronic Phase of Chronic Myeloid Leukemia Patients Treated with Imatinib

Hubungan ekspresi gen stat5a dan stat5b dengan pencapaian major molecular response (MMR) pada pasien leukemia granulositik kronik yang mendapat imatinib = Expression of stat5a and stat5b and its relation to achievement of major molecular response in patient with chronic phase chronic myeloid leukemia on imatinib treatment